Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gitte Fredberg Persson is active.

Publication


Featured researches published by Gitte Fredberg Persson.


Radiotherapy and Oncology | 2010

Deviations in delineated GTV caused by artefacts in 4DCT

Gitte Fredberg Persson; Ditte Eklund Nygaard; Carsten Brink; Jonas Westberg Jahn; Per Munck af Rosenschöld; Lena Specht; S. Korreman

BACKGROUND AND PURPOSE Four-dimensional computed tomography (4DCT) is used for breathing-adapted radiotherapy planning. Irregular breathing, large tumour motion or interpolation of images can cause artefacts in the 4DCT. This study evaluates the impact of artefacts on gross tumour volume (GTV) size. MATERIAL AND METHODS In 19 4DCT scans of patients with peripheral lung tumours, GTV was delineated in all bins. Variations in GTV size between bins in each 4DCT scan were analysed and correlated to tumour motion and variations in breathing signal amplitude and breathing signal period. End-expiration GTV size (GTVexp) was considered as reference for GTV size. Intra-session delineation error was estimated by re-delineation of GTV in eight of the 4DCT scans. RESULTS In 16 of the 4DCT scans the maximum deviations from GTVexp were larger than could be explained by delineation error. The deviations were largest in the bins adjacent to the end-inspiration bin. The coefficient of variation of GTV size was significantly correlated to tumour motion in the cranio-caudal direction, but no significant correlation was found to breathing signal variations. CONCLUSION We found considerable variations in GTV size throughout the 4DCT scans. Awareness of the error introduced by artefacts is important especially if radiotherapy planning is based on a single 4DCT bin.


Acta Oncologica | 2008

Interfractional changes in tumour volume and position during entire radiotherapy courses for lung cancer with respiratory gating and image guidance

Trine Juhler-Nøttrup; S. Korreman; Anders N. Pedersen; Gitte Fredberg Persson; Lasse Rye Aarup; Håkan Nyström; Mikael Olsen; Nikolai Tarnavski; Lena Specht

Introduction. With the purpose of implementing gated radiotherapy for lung cancer patients, this study investigated the interfraction variations in tumour size and internal displacement over entire treatment courses. To explore the potential of image guided radiotherapy (IGRT) the variations were measured using a set-up strategy based on imaging of bony landmarks and compared to a strategy using in room lasers, skin tattoos and cupper landmarks. Materials and methods. During their six week treatment course of 60Gy in 2Gy fractions, ten patients underwent 3 respiratory gated CT scans. The tumours were contoured on each CT scan to evaluate the variations in volumes and position. The lung tumours and the mediastinal tumours were contoured separately. The positional variations were measured as 3D mobility vectors and correlated to matching of the scans using the two different strategies. Results. The tumour size was significantly reduced from the first to the last CT scan. For the lung tumours the reduction was 19%, p=0.03, and for the mediastinal tumours the reduction was 34%, p=0.0007. The mean 3D mobility vector and the SD for the lung tumours was 0.51cm (±0.21) for matching using bony landmarks and 0.85cm (±0.54) for matching using skin tattoos. For the mediastinal tumours the corresponding vectors and SDs were 0.55cm (±0.19) and 0.72cm (±0.43). The differences between the vectors were significant for the lung tumours p=0.004. The interfractional overlap of lung tumours was 80–87% when matched using bony landmarks and 70–76% when matched using skin tattoos. The overlap of the mediastinal tumours were 60–65% and 41–47%, respectively. Conclusions. Despite the use of gating the tumours varied considerably, regarding both position and volume. The variations in position were dependent on the set-up strategy. Set-up using IGRT was superior to set-up using skin tattoos.


Acta Oncologica | 2009

DMLC motion tracking of moving targets for intensity modulated arc therapy treatment – a feasibility study

Jens Zimmerman; S. Korreman; Gitte Fredberg Persson; Herb Cattell; Michelle Marie Svatos; Amit Sawant; Raghu Venkat; David J. Carlson; P Keall

Purpose. Intensity modulated arc therapy offers great advantages with the capability of delivering a fast and highly conformal treatment. However, moving targets represent a major challenge. By monitoring a moving target it is possible to make the beam follow the motion, shaped by a Dynamic MLC (DMLC). The aim of this work was to evaluate the dose delivered to moving targets using the RapidArcTM (Varian Medical Systems, Inc.) technology with and without a DMLC tracking algorithm. Material and methods. A Varian Clinac iX was equipped with a preclinical RapidArcTM and a 3D DMLC tracking application. A motion platform was placed on the couch, with the detectors on top: a PTW seven29 and a Scandidos Delta4. One lung plan and one prostate plan were delivered. Motion was monitored using a Real-time Position Management (RPM) system. Reference measurements were performed for both plans with both detectors at state (0) “static, no tracking”. Comparing measurements were made at state (1) “motion, no tracking” and state (2) “motion, tracking”. Results. Gamma analysis showed a significant improvement from measurements of state (1) to measurements of state (2) compared to the state (0) measurements: Lung plan; from 87 to 97% pass. Prostate plan; from 81 to 88% pass. Sub-beam information gave a much reduced pattern of periodically spatial deviating dose points for state (2) than for state (1). Iso-dose curve comparisons showed a slightly better agreement between state (0) and state (2) than between state (0) and state (1). Conclusions. DMLC tracking together with RapidArcTM make a feasible combination and is capable of improving the dose distribution delivered to a moving target. It seems to be of importance to minimize noise influencing the tracking, to gain the full benefit from the application.


Acta Oncologica | 2008

The role of image guidance in respiratory gated radiotherapy

S. Korreman; Trine Juhler-Nøttrup; Gitte Fredberg Persson; Anders N. Pedersen; Marika Enmark; Håkan Nyström; Lena Specht

Respiratory gating for radiotherapy beam delivery is a widely available technique, manufactured and sold by most of the major radiotherapy machine vendors. Respiratory gated beam delivery is intended to limit the irradiation of tumours moving with respiration to selected parts of the respiratory cycle, and thereby enable dose escalation and/or reduction of dose to organs at risk. Without adequate use of respiratory correlated image guidance on a regular basis, respiratory beam gating may however have a detrimental effect on target coverage. Image guidance of tumour respiratory motion is therefore of utmost importance for the safe introduction of respiratory gating. In this short overview, suitable image guidance strategies for respiratory gated radiotherapy are reviewed for two cancer sites; breast cancer and lung tumours.


Acta Oncologica | 2012

Translational and rotational intra- and inter-fractional errors in patient and target position during a short course of frameless stereotactic body radiotherapy

Mirjana Josipovic; Gitte Fredberg Persson; Áshildur Logadottir; B. Smulders; Gunnar Westmann; J.P. Bangsgaard

Abstract Background. Implementation of cone beam computed tomography (CBCT) in frameless stereotactic body radiotherapy (SBRT) of lung tumours enables setup correction based on tumour position. The aim of this study was to compare setup accuracy with daily soft tissue matching to bony anatomy matching and evaluate intra- and inter-fractional translational and rotational errors in patient and target positions. Material and methods. Fifteen consecutive SBRT patients were included in the study. Vacuum cushions were used for immobilisation. SBRT plans were based on midventilation phase of four-dimensional (4D)-CT or three-dimensional (3D)-CT from PET/CT. Margins of 5 mm in the transversal plane and 10 mm in the cranio-caudal (CC) direction were applied. SBRT was delivered in three fractions within a week. At each fraction, CBCT was performed before and after the treatment. Setup accuracy comparison between soft tissue matching and bony anatomy matching was evaluated on pretreatment CBCTs. From differences in pre- and post-treatment CBCTs, we evaluated the extent of translational and rotational intra-fractional changes in patient position, tumour position and tumour baseline shift. All image registration was rigid with six degrees of freedom. Results. The median 3D difference between patient position based on bony anatomy matching and soft tissue matching was 3.0 mm (0–8.3 mm). The median 3D intra-fractional change in patient position was 1.4 mm (0–12.2 mm) and 2.2 mm (0–13.2 mm) in tumour position. The median 3D intra-fractional baseline shift was 2.2 mm (0–4.7 mm). With correction of translational errors, the remaining systematic and random errors were approximately 1°. Conclusion. Soft tissue tumour matching improved precision of treatment delivery in frameless SBRT of lung tumours compared to image guidance using bone matching. The intra-fractional displacement of the target position was affected by both translational and rotational changes in tumour baseline position relative to the bony anatomy and by changes in patient position.


International Journal of Radiation Oncology Biology Physics | 2012

Respiration-Correlated Image Guidance Is the Most Important Radiotherapy Motion Management Strategy for Most Lung Cancer Patients

S. Korreman; Gitte Fredberg Persson; Ditte Eklund Nygaard; Carsten Brink; Trine Juhler-Nøttrup

PURPOSE The purpose of this study was to quantify the effects of four-dimensional computed tomography (4DCT), 4D image guidance (4D-IG), and beam gating on calculated treatment field margins in a lung cancer patient population. MATERIALS AND METHODS Images were acquired from 46 lung cancer patients participating in four separate protocols at three institutions in Europe and the United States. Seven patients were imaged using fluoroscopy, and 39 patients were imaged using 4DCT. The magnitude of respiratory tumor motion was measured. The required treatment field margins were calculated using a statistical recipe (van Herk M, et al. Int J Radiat Oncol Biol Phys 2000;474:1121-1135), with magnitudes of all uncertainties, except respiratory peak-to-peak displacement, the same for all patients, taken from literature. Required margins for respiratory motion management were calculated using the residual respiratory tumor motion for each patient for various motion management strategies. Margin reductions for respiration management were calculated using 4DCT, 4D-IG, and gated beam delivery. RESULTS The median tumor motion magnitude was 4.4 mm for the 46 patients (range 0-29.3 mm). This value corresponded to required treatment field margins of 13.7 to 36.3 mm (median 14.4 mm). The use of 4DCT, 4D-IG, and beam gating required margins that were reduced by 0 to 13.9 mm (median 0.5 mm), 3 to 5.2 mm (median 5.1 mm), and 0 to 7 mm (median 0.2 mm), respectively, to a total of 8.5 to 12.4 mm (median 8.6 mm). CONCLUSION A respiratory management strategy for lung cancer radiotherapy including planning on 4DCT scans and daily image guidance provides a potential reduction of 37% to 47% in treatment field margins. The 4D image guidance strategy was the most effective strategy for >85% of the patients.


Acta Oncologica | 2008

Can audio coached 4D CT emulate free breathing during the treatment course

Gitte Fredberg Persson; Ditte Eklund Nygaard; Mikael Olsen; Trine Juhler-Nøttrup; Anders N. Pedersen; Lena Specht; S. Korreman

Background. The image quality of 4DCT depends on breathing regularity. Respiratory audio coaching may improve regularity and reduce motion artefacts. We question the safety of coached planning 4DCT without coaching during treatment. We investigated the possibility of coaching to a more stable breathing without changing the breathing amplitude. The interfraction variation of the breathing cycle amplitude in free and coached breathing was studied as well as the possible impact of fatigue on longer coaching sessions. Methods. Thirteen volunteers completed respiratory audio coaching on 3 days within a 2 week period. An external marker system monitoring the motion of the thoraco-abdominal wall was used to track the respiration. On all days, free breathing and two coached breathing curves were recorded. We assumed that free versus coached breathing from day 1 (reference session) simulated breathing during an uncoached versus coached planning 4DCT, respectively, and compared the mean breathing cycle amplitude to the free versus coached breathing from day 2 and 3 simulating free versus coached breathing during treatment. Results. For most volunteers it was impossible to apply coaching without changes in breathing cycle amplitude. No significant decrease in standard deviation of breathing cycle amplitude distribution was seen. Generally it was not possible to predict the breathing cycle amplitude and its variation the following days based on the breathing in the reference session irrespective of coaching or free breathing. We found a significant tendency towards an increased breathing cycle amplitude variation with the duration of the coaching session. Conclusion. These results suggest that large interfraction variation is present in breathing amplitude irrespective of coaching, leading to the suggestion of daily image guidance for verification of respiratory pattern and tumour related motion. Until further investigated it is not recommendable to use coached 4DCT for planning of a free breathing treatment course.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2015

Prognostic value of 18F-fludeoxyglucose uptake in 287 patients with head and neck squamous cell carcinoma.

Jacob H. Rasmussen; Ivan R. Vogelius; Barbara M. Fischer; Jeppe Friborg; Marianne C. Aznar; Gitte Fredberg Persson; K. Håkansson; Claus Kristensen; Søren M. Bentzen; Lena Specht

The prognostic value of 18F‐Fludeoxyglucose (FDG) uptake could be due to its association with already known clinical risk factors.


Acta Oncologica | 2013

Deep inspiration breath hold radiotherapy for locally advanced lung cancer: Comparison of different treatment techniques on target coverage, lung dose and treatment delivery time

Mirjana Josipovic; Gitte Fredberg Persson; K. Håkansson; Sidsel Marie Skov Damkjær; J.P. Bangsgaard; Gunnar Westman; Steen Riisgaard; Lena Specht; Marianne C. Aznar

Lanhede B , B å th M , Kheddache S , Sund P , Bj ö rneld L , [19] Widell M , et al . The infl uence of different technique factors on image quality of chest radiographs as evaluated by modifi ed CEC image quality criteria . Br J Radiol 2002 ; 75 : 38 – 49 . M å nsson L . Methods for the evaluation of image quality: [20] A review . Radiat Prot Dosimetry 2000 ; 90 : 89 – 99 . Van Erkel AR , Pattynama PMT . Receiver operating charac[21] teristic (ROC) analysis: Basic principles and applications in radiology . Eur J Radiol 1998 ; 27 : 88 – 94 . Stock M , Pasler M , Birkfellner W , Homolka P , Poetter R , [22] Georg D . Image quality and stability of image-guided radiotherapy (IGRT) devices: A comparative study . Radiother Oncol 2009 ; 93 : 1 – 7 . Lou Y , Niu T , Jia X , Vela PA , Zhu L , Tannenbaum AR . [23] Joint CT/CBCT deformable registration and CBCT enhancement for cancer radiotherapy . Med Image Anal 2013 ; 17 : 387 – 400 . Niu T , Al-Basheer A , Zhu L . Quantitative cone-beam CT [24] imaging in radiation therapy using planning CT as a prior: First patient studies . Med Phys 2012 ; 39 : 1991 – 2000 . Poludniowski G , Evans PM , Hansen VN , Webb S . An effi [25] cient Monte Carlo-based algorithm for scatter correction in keV cone-beam CT . Phys Med Biol 2009 ; 54 : 3847 – 64 . Mainegra-Hing E , Kawrakow I . Variance reduction tech[26] niques for fast Monte Carlo CBCT scatter correction calculations . Phys Med Biol 2010 ; 55 : 4495 – 507 . Jina JY , Ren L , Liu Q , Kim J , Wen N , Guan H , et al . Com[27] bining scatter reduction and correction to improve image quality in cone-beam computed tomography (CBCT) . Med Phys 2010 ; 37 : 5634 – 44 . Qiu W , Pengpan T , Smith ND , Soleimani M . Evaluating [28] iterative algebraic algorithms in terms of convergence and image quality for cone beam CT . Comput Methods Programs Biomed 2013 ; 109 : 313 – 22 . Kamath S , Song W , Chvetsov A , Ozawa S , Lu H , Samant S , [29] et al . An image quality comparison study between XVI and OBI CBCT systems . J Appl Clin Med Phys 2011 ; 12 : 376 – 90 . Kim S , Yoo S , Yin FF , Samei E , Yoshizumi T . Kilovoltage [30] cone-beam CT: Comparative dose and image quality evaluations in partial and full-angle scan protocols . Med Phys 2010 ; 37 : 3648 – 59 . Elstr ø m UV , Muren LP , Petersen JB , Grau C . Evaluation of [31] image quality for different kV cone-beam CT acquisition and reconstruction methods in the head and neck region . Acta Oncol 2011 ; 50 : 908 – 17 .


Radiotherapy and Oncology | 2016

Liquid fiducial marker performance during radiotherapy of locally advanced non small cell lung cancer

Jonas Scherman Rydhög; Steen Riisgaard Mortensen; Klaus Richter Larsen; Paul Clementsen; Rasmus Irming Jølck; Mirjana Josipovic; Marianne C. Aznar; Lena Specht; Thomas Lars Andresen; Per Munck af Rosenschöld; Gitte Fredberg Persson

BACKGROUND AND PURPOSE We analysed the positional and structural stability of a long-term biodegradable liquid fiducial marker (BioXmark) for radiotherapy in patients with locally advanced lung cancer. MATERIAL AND METHODS Markers were injected via endoscopic- or endobronchial ultrasound in lymph nodes and reachable primary tumours. Marker volume and Hounsfield Units (HU) changing rates were estimated using breath-hold CBCT. Inter-fraction variation in marker position relative to gross tumour volume (GTV) position was established, as well as the inter-fraction variation in mediastinal marker registration relative to a carina registration through the treatment. RESULTS Fifteen patients were included and 29 markers analysed. All markers that were in situ at planning were visible through the treatment. Mean HU was 902±165HU for lymph node and 991±219HU for tumour markers. Volume degradation rates were -5% in lymph nodes and -23% in primary tumours. Three-dimensional inter-fraction variation for marker position relative to the GTV position was -0.1±0.7mm in lymph nodes and -1.5±2.3mm in primary tumours. Inter-fraction variations in marker registration relative to carina registration were -0.4±1.2mm in left-right, 0.2±2.0mm in anterior-posterior and -0.5±2.0mm in cranio-caudal directions. CONCLUSIONS The liquid fiducial markers were visible and stable in size and position throughout the treatment course.

Collaboration


Dive into the Gitte Fredberg Persson's collaboration.

Top Co-Authors

Avatar

Lena Specht

University of Copenhagen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

S. Korreman

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar

Carsten Brink

University of Southern Denmark

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ditte Eklund Nygaard

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar

Rasmus Irming Jølck

Technical University of Denmark

View shared research outputs
Top Co-Authors

Avatar

J.P. Bangsgaard

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge